The Nevada Gaming Control Board (NGCB) accepted the surrender of DraftKings and FanDuel license applications on Wednesday. Both businesses are abandoning plans to enter the Nevada sports betting ...

FDA accepted Replimune’s resubmitted Biologics License Application for RP1 combined with Bristol Myers Squibb’s Opdivo to treat advanced melanoma The agency set April 10, 2026 as the decision deadline ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

As of Wednesday, building contractors, business owners and residents in St. Paul will be able to do something many may have assumed was long available, but wasn’t — submit permit and license ...

PennDOT issues many vanity license plates annually, but it also rejects countless applications, from the puerile to the racist, according to a staff report from City & State Pennsylvania. Over at ...

Replimune (NASDAQ:REPL) climbed more than 100% on Wednesday as Cantor Fitzgerald upgraded the cancer drug developer, citing a potential reversal of an FDA decision that rejected its lead drug ...

Replimune (NASDAQ:REPL) announced on Tuesday that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter regarding its marketing application for its lead asset, RP1, declining ...

Replimune Group, Inc. (NASDAQ:REPL) stock plunged on Tuesday after a U.S. Food and Drug Administration (FDA) update. The clinical stage biotechnology company received an FDA Complete Response Letter ...

Multiple analysts have issued price targets for $REPL recently. We have seen 4 analysts offer price targets for $REPL in the last 6 months, with a median target of ...

SINGAPORE, July 9 (Reuters) - Singapore-headquartered financial technology company Ant International is "seriously considering" stablecoin license applications in multiple jurisdictions around the ...